Back

Atrial substrate burden determines mitral regurgitation improvement after low-voltage area ablation: a post-hoc analysis of the SUPPRESS-AF randomized trial

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Atrial substrate and atrial fibrillation outcomes Rhythm Control, Catheter Ablation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ayako Sugino

Osaka Rosai Hospital, Osaka (Japan)

6 More presentations in this session

Presentation thumbnail
BMI-dependent sex differences in atrial tachyarrhythmia recurrence despite greater low-voltage substrate in women: a SUPPRESS-AF subgroup analysis
Doctor N. Tanaka (Osaka, JP)
Abstract Slides
Presentation thumbnail
Impact of substrate modification and shift in recurrence pattern in elderly patients with persistent atrial fibrillation: a sub-analysis of the SUPPRESS-AF trial
Doctor T. Kanda (Osaka, JP)
Abstract Slides
Presentation thumbnail
Right atrial structural remodeling outweighs frequency-defined drivers in persistent atrial fibrillation: the multicenter randomized PAD-AF trial
Doctor K. Matsuda (Sendai, JP)
Abstract Slides
Presentation thumbnail
ALDAS score for low-voltage area burden identifies differential benefit of low-voltage-guided ablation in persistent atrial fibrillation: insights from the SUPPRESS-AF trial
Doctor A. Sunaga (Suita, JP)
Abstract Slides
Presentation thumbnail
Impact of the right atrial substrate on arrhythmia recurrence following atrial fibrillation ablation
Doctor N. Bodagh (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Atrial substrate and atrial fibrillation outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Identifying suitable candidates for left atrial low-voltage area ablation in persistent atrial fibrillation: a post-hoc analysis of the SUPPRESS-AF trial
1 September 2025
thumbnail
Congress Presentation
Reverse remodelling as the key to improve secondary mitral regurgitation
29 June 2021
thumbnail
Congress Presentation
Arrhythmic mitral valve prolapse with versus without prior mitral valve repair: clinical profiles, electrophysiological substrates, and long-term clinical outcomes
9 April 2024
thumbnail
Congress Presentation
Impact of catheter ablation on functional tricuspid regurgitation in patients with atrial fibrillation
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources